Engerix™-B Kinder
Sponsors
GlaxoSmithKline
Conditions
Hepatitis BHepatitis B Vaccine
Phase 4
Persistence of Hepatitis B Antibody Levels & Immune Response to a Hepatitis B Vaccine Challenge
CompletedNCT00411697
Start: 2006-12-31End: 2007-05-31Updated: 2016-10-28
Long-term Persistence of Immunity Against Hepatitis B in 7-8 Years Old Children After Hepatitis B Vaccination.
CompletedNCT00519649
Start: 2007-08-31End: 2007-12-31Updated: 2018-08-17
Persistence of Immunity Against Hepatitis B in 12-13 Year Old Adolescents After Infant Hepatitis B Vaccination
CompletedNCT00984139
Start: 2009-10-12End: 2010-04-07Updated: 2018-08-20
Evaluation of the Long-term Persistence of Immunity to Hepatitis B, in Adolescents Vaccinated in Infancy With Engerix™-B Kinder
CompletedNCT01847430
Start: 2013-07-19End: 2014-02-21Updated: 2018-08-20
This Study Aims to Determine the Long-term Persistence of Antibodies Against Hepatitis B and to Evaluate the Immunogenicity and Safety of Hepatitis B Vaccine in Adolescents Vaccinated in Infancy With Infanrix™ Hexa
CompletedNCT02052661
Start: 2014-02-18End: 2014-09-23Updated: 2018-06-06